NCT01978587View on ClinicalTrials.gov

Effect of Hemodialysis on the PK of JTZ-951 in Subjects With End-stage Renal Disease

PHASE1CompletedINTERVENTIONAL

Enrollment

6

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

December 31, 2013

Study Completion Date

January 31, 2014

Conditions

Anemia in Chronic Kidney Disease

Interventions

DRUG

JTZ-951

Trial Locations (1)

Unknown

Minneapolis

Sponsors

Lead Sponsor

Akros Pharma Inc.

All Listed Sponsors

lead

Akros Pharma Inc.

INDUSTRY

NCT01978587 - Effect of Hemodialysis on the PK of JTZ-951 in Subjects With End-stage Renal Disease | Biotech Hunter | Biotech Hunter